Atlas Trials

BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination

Clinical trial NCT03991442 · COMPLETED

Trial details

NCT number
NCT03991442
Sponsor
Boryung Pharmaceutical Co., Ltd
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Essential Hypertension
Start date
2019-06-17
Primary completion
2021-03-02
Enrollment
257

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.